✦ LIBER ✦

Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial

✍ Scribed by Joseph J Eron Jr; Jürgen K Rockstroh; Jacques Reynes; Jaime Andrade-Villanueva; Jose Valdez Ramalho-Madruga; Linda-Gail Bekker; Benjamin Young; Christine Katlama; Jose Maria Gatell-Artigas; Jose R Arribas; Mark Nelson; Havilland Campbell; Jing Zhao; Anthony J Rodgers; Matthew L Rizk; Larissa Wenning; Michael D Miller; Daria Hazuda; Mark J DiNubile; Randi Leavitt; Robin Isaacs; Michael N Robertson; Peter Sklar; Bach-Yen Nguyen

Book ID: 118626475
Publisher: The Lancet
Year: 2011
Tongue: English
Weight: 253 KB
Volume: 11
Category: Article
ISSN: 1473-3099
DOI: 10.1016/s1473-3099(11)70196-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of once daily elvite

Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study

✍ Jean-Michel Molina; Anthony LaMarca; Jaime Andrade-Villanueva; Bonaventura Clote 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 209 KB

Once-daily dolutegravir versus twice-dai

Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial

✍ Raffi, François; Jaeger, Hans; Quiros-Roldan, Eugenia; Albrecht, Helmut; Belonos 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 274 KB

Once-weekly dulaglutide versus once-dail

Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial

✍ Dungan, Kathleen M; Povedano, Santiago Tofé; Forst, Thomas; González, José G Gon 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 535 KB

Once-weekly albiglutide versus once-dail

Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study

✍ Pratley, Richard E; Nauck, Michael A; Barnett, Anthony H; Feinglos, Mark N; Oval 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 288 KB

Thoracic radiotherapy with or without da

Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301)

✍ Shinji Atagi; Masaaki Kawahara; Akira Yokoyama; Hiroaki Okamoto; Nobuyuki Yamamo 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 216 KB